Cargando…

Preliminary Results about Application of Intensity-Modulated Radiotherapy to Reduce Prophylactic Radiation Dose in Limited-Stage Small Cell Lung Cancer

To evaluate the clinical outcomes of simultaneous dose reduction of elective nodal area with intensity-modulated radiotherapy (SIR-IMRT) versus conventional IMRT (C-IMRT) in patients with limited-stage small-cell lung cancer (LS-SCLC), patients with LS-SCLC who received definitive SIR-IMRT or C-IMRT...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhiyan, Wang, Jing, Yuan, Zhiyong, Zhang, Baozhong, Gong, Linlin, Zhao, Lujun, Wang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072822/ https://www.ncbi.nlm.nih.gov/pubmed/30087702 http://dx.doi.org/10.7150/jca.24976

Ejemplares similares

Simultaneous integrated dose reduction intensity-modulated radiotherapy applied to an elective nodal area of limited-stage small-cell lung cancer
por: LIU, ZHIYAN, et al.
Publicado: (2015)

Simultaneous integrated dose reduction intensity-modulated radiotherapy effectively reduces cardiac toxicity in limited-stage small cell lung cancer
por: Luo, Jing, et al.
Publicado: (2023)

Nomograms for predicting progression and efficacy of post-operation radiotherapy in IIIA-pN2 non-small cell lung cancer patients
por: Zhang, Baozhong, et al.
Publicado: (2017)

Preliminary analysis of the risk factors for radiation pneumonitis in patients with non-small-cell lung cancer treated with concurrent erlotinib and thoracic radiotherapy
por: Zhuang, Hongqing, et al.
Publicado: (2014)

The influence of the metastasis pattern of mediastinal lymph nodes on the postoperative radiotherapy’s efficacy for the IIIA-pN2 non-small-cell lung cancer: a retrospective analysis of 220 patients
por: Zhang, Baozhong, et al.
Publicado: (2016)

Prophylactic cranial irradiation-related lymphopenia affects survival in patients with limited-stage small cell lung cancer
por: Fan, Xinyu, et al.
Publicado: (2023)

Clinical results of intensity-modulated radiotherapy for 250 patients with cervical and upper thoracic esophageal carcinoma
por: Zhang, Jiaqi, et al.
Publicado: (2019)

Does the response to induction chemotherapy impact the timing of thoracic radiotherapy for limited-stage small-cell lung cancer?
por: Wang, Peng, et al.
Publicado: (2015)

Timing of thoracic radiotherapy in the treatment of extensive-stage small-cell lung cancer: important or not?
por: Luo, Jing, et al.
Publicado: (2017)

The Impact of Clinical Stage on Radiation Doses to Organs at Risk Following Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma: A Prospective Analysis
por: Xu, Lin, et al.
Publicado: (2016)

A Preliminary Note on the Prophylactic Value of Fortnightly Doses of Camoquin in Malaria
por: Chaudhuri, R. N., et al.
Publicado: (1952)

Optimal dose limitation strategy for bone marrow sparing in intensity-modulated radiotherapy of cervical cancer
por: Bao, Zhirong, et al.
Publicado: (2019)

Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative intensity modulated radiotherapy for early-stage cervical cancer
por: Chen, Zhongjie, et al.
Publicado: (2014)

Low radiotherapy dose is suitable for brain metastases in SCLC compared with high dose
por: Xu, Liming, et al.
Publicado: (2023)

Improving stereotactic radiotherapy (SRT) planning process for brain metastases by Cyberknife system: reducing dose distribution in healthy tissues
por: Xuyao, Yu, et al.
Publicado: (2020)

Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose
por: Kwak, Yoo-Kang, et al.
Publicado: (2017)

SIRPα blockade improves the antitumor immunity of radiotherapy in colorectal cancer
por: Ji, Kai, et al.
Publicado: (2023)

Outcome of dose-escalated intensity-modulated radiotherapy for limited disease small cell lung cancer
por: Yang, Eunyeong, et al.
Publicado: (2023)

Clinical features and treatment of squamous cell carcinoma of the breast
por: Zhang, Ximei, et al.
Publicado: (2016)

Prophylactic radiotherapy in retinoblastoma--is it really new?
por: Donaldson, S. S.
Publicado: (1993)

Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
por: Chen, Yang, et al.
Publicado: (2016)

One Cycle of Concurrent Chemotherapy vs. Two Cycles of Concurrent Chemotherapy With Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer
por: Yu, Hao, et al.
Publicado: (2022)

Intermediate Dose-Volume Parameters, Not Low-Dose Bath, Is Superior to Predict Radiation Pneumonitis for Lung Cancer Treated With Intensity-Modulated Radiotherapy
por: Meng, Yinnan, et al.
Publicado: (2020)

Impact of radiation dose on concurrent chemoradiotherapy for limited-stage small-cell lung cancer
por: Park, Junhee, et al.
Publicado: (2018)

Prophylactic cranial irradiation for limited‐stage small‐cell lung cancer in the magnetic resonance imaging era
por: Pan, Lihua, et al.
Publicado: (2022)

The efficacy and safety of simultaneous integrated dose reduction in clinical target volume with intensity-modulated radiotherapy for patients with locally advanced esophageal squamous cell carcinoma
por: Zhao, Jingjing, et al.
Publicado: (2020)

Clinical outcome for small cell lung cancer patients with bone metastases at the time of diagnosis
por: Gong, Linlin, et al.
Publicado: (2019)

Correction: Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer
por: Chen, Yang, et al.
Publicado: (2018)

A prospective study on radiation doses to organs at risk (OARs) during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients
por: Yao, Ji-Jin, et al.
Publicado: (2016)

Benefits of Prophylactic Cranial Irradiation in the MRI Era for Patients With Limited Stage Small Cell Lung Cancer
por: Qi, Chao, et al.
Publicado: (2022)

Dose optimization strategy of sacrum limitation in cervical cancer intensity modulation radiation therapy planning
por: Guo, Qi, et al.
Publicado: (2019)

Intensity modulated radiotherapy: advantages, limitations and future developments
por: Cheung, KY
Publicado: (2006)

Prophylactic Bilateral Nipple-sparing Mastectomy and a Staged Breast Reconstruction Technique: Preliminary Results
por: Tondu, Thierry, et al.
Publicado: (2016)

A Case of Radiation Recall Dermatitis of Scalp in Acute Lymphoblastic Leukemia After Prophylactic Cranial Radiotherapy
por: Madasamy, Ponraj, et al.
Publicado: (2017)

Locoregional recurrence-associated factors and risk-adapted postmastectomy radiotherapy for breast cancer staged in cT1-2N0-1 after neoadjuvant chemotherapy
por: Wang, Xin, et al.
Publicado: (2018)

Radiation-induced late dysphagia after intensity-modulated radiotherapy in nasopharyngeal carcinoma patients: a dose-volume effect analysis
por: Jiang, Li, et al.
Publicado: (2018)

The effect of bioequivalent radiation dose on survival of patients with limited-stage small-cell lung cancer
por: Xia, Bing, et al.
Publicado: (2011)

Distribution of regional lymph lode metastasis in unilateral nasopharyngeal carcinoma and the suggestions for selective prophylactic irradiation with intensity‐modulated radiotherapy
por: Lin, Feifei, et al.
Publicado: (2023)

Thoracic Radiotherapy Benefits Elderly Extensive-Stage Small Cell Lung Cancer Patients with Distant Metastasis
por: Qi, Jing, et al.
Publicado: (2019)

Treatment time to the end of thoracic radiotherapy has more predictive power for survival than radiation dose intensity in patients with limited-stage small-cell lung cancer receiving concurrent chemoradiation of more than 45 Gy
por: Jeong, Jae-Uk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_b6489g6n6i09oe9k2tp2o6gq7e